Phase 4 Depression and Anxiety Trial, Recruiting NCT07192367 Sponsor: Emine Kanmaz Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT07192367
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have attended the Child and Adolescent Psychiatry Outpatient Clinic at Kocaeli University
  • Young people between 12 and 17 years of age
  • People who have been diagnosed with Social Anxiety Disorder (SAD)
  • People who are not currently taking any medication for Social Anxiety Disorder
  • People assessed as having normal intelligence based on clinical observation
  • People who have chosen not to take medication that was recommended for their Social Anxiety Disorder (research arm and one control group)
  • People in the control group who are willing to take sertraline, a medication routinely used for Social Anxiety Disorder in outpatient clinic follow-ups
  • People who have agreed to take part voluntarily, after seeing an invitation poster about the study
  • People for whom written consent to participate has been provided by the young person and/or a parent or authorised family member

Who may not be able to join:

  • People with a substance use disorder
  • People with a diagnosis of schizophrenia or bipolar disorder
  • People with autism spectrum disorder
  • People with a cognitive disability (intellectual disability)
  • People with a neurological disorder (research arm only — confirm with trial site)
  • People with a balance disorder (research arm only — confirm with trial site)
  • People who have received SSRI medication (a type of antidepressant) for Social Anxiety Disorder within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Nursu Çakın Memik, MD, Prof., Kocaeli University, Department of Child and Adolescent Psychiatry

Phone: +905557452890

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Emine Kanmaz
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in Social Anxiety Symptoms (Liebowitz Social Anxiety Scale, LSAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov